Physician profile
Sujan Ravi
NPI 1649584350
$5,808.77
in general payments reported to CMS, 2019-2025
11 companies · $4,901 in 2025
The $4,901 reported for 2025 was more than what 90% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $35.23 · 2022: $58.48 · 2024: $396 · 2025: $4,901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,750 · Travel and Lodging: $1,643 · Food and Beverage: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,750.00 |
| Travel and Lodging | $1,643.17 |
| Food and Beverage | $903.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $2,240.88 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $2,002.56 | 2024-2025 | Iqirvo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $653.47 | 2019-2025 | Xifaxan |
| Gilead Sciences, INC. | $334.44 | 2022-2025 | Livdelzi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2019 | |
| Mirum Pharmaceuticals, INC. | $123.65 | 2025 | Livmarli |
| Janssen Biotech, INC. | $122.24 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $103.48 | 2024 | Terlivaz |
| Abbvie INC. | $59.34 | 2019 | |
| Alexion Pharmaceuticals, INC. | $29.56 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sujan Ravi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.